Agilent Technologies, Inc. $A Shares Sold by SVB Wealth LLC

SVB Wealth LLC reduced its position in shares of Agilent Technologies, Inc. (NYSE:A) by 46.9% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 6,246 shares of the medical research company’s stock after selling 5,511 shares during the period. SVB Wealth LLC’s holdings in Agilent Technologies were worth $712,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in A. Bridgefront Capital LLC acquired a new stake in Agilent Technologies during the 3rd quarter worth $1,323,000. Wellington Management Group LLP raised its position in shares of Agilent Technologies by 4.8% in the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock valued at $1,203,990,000 after buying an additional 433,342 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of Agilent Technologies by 4.3% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock valued at $82,712,000 after buying an additional 24,687 shares during the last quarter. Generation Investment Management LLP lifted its stake in shares of Agilent Technologies by 10.1% in the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock worth $816,043,000 after buying an additional 582,093 shares in the last quarter. Finally, Champlain Investment Partners LLC lifted its stake in shares of Agilent Technologies by 33.3% in the third quarter. Champlain Investment Partners LLC now owns 895,770 shares of the medical research company’s stock worth $114,972,000 after buying an additional 223,750 shares in the last quarter.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $126.95 on Wednesday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The company has a 50-day moving average price of $121.94 and a 200 day moving average price of $126.44. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27. The stock has a market cap of $35.85 billion, a P/E ratio of 25.49, a PEG ratio of 2.25 and a beta of 1.26.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period in the previous year, the business posted $1.31 EPS. Agilent Technologies’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 6 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be issued a $0.255 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on A shares. TD Cowen upped their price objective on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Barclays boosted their target price on Agilent Technologies from $140.00 to $145.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Wells Fargo & Company dropped their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. Finally, Royal Bank Of Canada initiated coverage on Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price objective on the stock. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $160.93.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.